欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DK/H/2930/004
药品名称
Atomoxetine Hydrochloride 40mg Capsules
活性成分
atomoxetine hydrochloride 40.0 mg
剂型
Capsule, hard
上市许可持有人
Teva B.V. Swensweg 5 2031 GA Haarlem Holland
参考成员国 - 产品名称
Denmark (DK)
互认成员国 - 产品名称
Germany (DE)
Netherlands (NL)
Atomoxetine Teva 40 mg, harde capsules
Portugal (PT)
Norway (NO)
Iceland (IS)
Atomoxetin Actavis 40 mg hart hylki
Sweden (SE)
Czechia (CZ)
Atomoxetin Actavis 40 mg
Slovakia (SK)
Atomoxetine Actavis 40 mg
许可日期
2016/02/15
最近更新日期
2024/04/11
药物ATC编码
N06BA09 atomoxetine
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final Labelling
|
Atomoxetine-DK_H_2930_001-007-OuP+ImP (Label+Blister)-27.07.20_clean
Date of last change:2021/02/16
Final PL
|
Atomoxetine-DK_H_2930_001-007-PIL-29.07.20_clean
Date of last change:2021/02/16
Final SPC
|
Atomoxetine-DK_H_2930_001-007-SmPC-29.07.20_clean
Date of last change:2021/02/16
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase